Activation of the Ral and Phosphatidylinositol 3′ Kinase Signaling Pathways by the Ras-Related Protein TC21
暂无分享,去创建一个
[1] A. Kimmelman,et al. R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells , 2000, Oncogene.
[2] Christian Ried,et al. Structural insights into phosphoinositide 3-kinase catalysis and signalling , 1999, Nature.
[3] P. Crespo,et al. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins , 1999, Oncogene.
[4] C. Der,et al. M-Ras/R-Ras3, a Transforming Ras Protein Regulated by Sos1, GRF1, and p120 Ras GTPase-activating Protein, Interacts with the Putative Ras Effector AF6* , 1999, The Journal of Biological Chemistry.
[5] J. Downward,et al. Multiple Ras Effector Pathways Contribute to G1Cell Cycle Progression* , 1999, The Journal of Biological Chemistry.
[6] Julian Downward,et al. Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell–matrix and cell–cell interaction , 1999, Current Biology.
[7] S. Oldham,et al. TC21 and Ras share indistinguishable transforming and differentiating activities , 1999, Oncogene.
[8] H. Paterson,et al. Activation of the Raf/MAP kinase cascade by the Ras‐related protein TC21 is required for the TC21‐mediated transformation of NIH 3T3 cells , 1999, The EMBO journal.
[9] K. Barker,et al. Ras-related TC21 is activated by mutation in a breast cancer cell line, but infrequently in breast carcinomas in vivo. , 1998, British Journal of Cancer.
[10] M. Mann,et al. Cell cycle progression: new therapeutic target for vascular proliferative disease. , 1998, Circulation.
[11] R. Wolthuis,et al. Activation of the Small GTPase Ral in Platelets , 1998, Molecular and Cellular Biology.
[12] Y. Matsuura,et al. Colocalization of Ras and Ral on the membrane is required for Ras-dependent Ral activation through Ral GDP dissociation stimulator , 1997, Oncogene.
[13] B. van der Burg,et al. Mitogenic Signaling of Insulin-like Growth Factor I in MCF-7 Human Breast Cancer Cells Requires Phosphatidylinositol 3-Kinase and Is Independent of Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.
[14] A. Kimmelman,et al. Identi ® cation and characterization of R-ras 3 : a novel member of the RAS gene family with a non-ubiquitous pattern of tissue distribution , 1997 .
[15] R. Wolthuis,et al. Stimulation of gene induction and cell growth by the Ras effector Rlf , 1997, The EMBO journal.
[16] J. Bos. Ras-like GTPases. , 1997, Biochimica et biophysica acta.
[17] J. Downward,et al. Interaction of Ras with phosphoinositide 3-kinase gamma. , 1997, The Biochemical journal.
[18] Asim Khwaja,et al. Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway , 1997, The EMBO journal.
[19] P. Warne,et al. Role of Phosphoinositide 3-OH Kinase in Cell Transformation and Control of the Actin Cytoskeleton by Ras , 1997, Cell.
[20] M. White,et al. RalGDS Functions in Ras- and cAMP-mediated Growth Stimulation* , 1997, The Journal of Biological Chemistry.
[21] G. Evan,et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.
[22] P. Warne,et al. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways , 1997, Current Biology.
[23] P. Tsichlis,et al. Akt Is a Direct Target of the Phosphatidylinositol 3-Kinase , 1996, The Journal of Biological Chemistry.
[24] C. Nobes,et al. Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways , 1996, Current Biology.
[25] Y. Matsuura,et al. Post-translational Modifications of Ras and Ral Are Important for the Action of Ral GDP Dissociation Stimulator* , 1996, The Journal of Biological Chemistry.
[26] L. J. van 't Veer,et al. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. , 1996, Oncogene.
[27] M. Wigler,et al. A Role for the Ral Guanine Nucleotide Dissociation Stimulator in Mediating Ras-induced Transformation* , 1996, The Journal of Biological Chemistry.
[28] M. Wigler,et al. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation , 1996, Molecular and cellular biology.
[29] J. Downward,et al. Activation of phosphoinositide 3‐kinase by interaction with Ras and by point mutation. , 1996, The EMBO journal.
[30] Gudrun Horn,et al. Differential Interaction of the Ras Family GTP-binding Proteins H-Ras, Rap1A, and R-Ras with the Putative Effector Molecules Raf Kinase and Ral-Guanine Nucleotide Exchange Factor , 1996, The Journal of Biological Chemistry.
[31] P. Hawkins,et al. Initiation and maintenance of NGF-stimulated neurite outgrowth requires activation of a phosphoinositide 3-kinase. , 1996, Journal of cell science.
[32] M. Barbacid,et al. The TC21 oncoprotein interacts with the Ral guanosine nucleotide dissociation factor. , 1996, Oncogene.
[33] T. Urano,et al. Ral‐GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. , 1996, The EMBO journal.
[34] C. Der,et al. Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers. , 1996, Oncogene.
[35] S. Aaronson,et al. A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line. , 1995, Oncogene.
[36] M. Barbacid,et al. Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation. , 1995, Oncogene.
[37] G. Cooper,et al. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. , 1995, Science.
[38] M. Wigler,et al. Multiple ras functions can contribute to mammalian cell transformation , 1995, Cell.
[39] P. Hawkins,et al. Activation of the small GTP-binding proteins rho and rac by growth factor receptors. , 1995, Journal of cell science.
[40] J. Bischoff,et al. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[41] C. Der,et al. R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells. , 1994, Oncogene.
[42] Michael J. Fry,et al. Phosphatidylinositol-3-OH kinase direct target of Ras , 1994, Nature.
[43] S. Aaronson,et al. A human oncogene of the RAS superfamily unmasked by expression cDNA cloning. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] C. Marshall,et al. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells , 1994, Cell.
[45] P. D’Eustachio,et al. Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation , 1994, Molecular and cellular biology.
[46] F. Grigorescu,et al. Involvement of phosphoinositide 3‐kinase in insulin‐ or IGF‐1‐induced membrane ruffling. , 1994, The EMBO journal.
[47] M. Kasuga,et al. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling , 1994, Current Biology.
[48] A. Hall,et al. R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation. , 1994, Oncogene.
[49] B. Dutrillaux,et al. Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma. , 1990, British Journal of Cancer.
[50] P. D’Eustachio,et al. Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line , 1990, Molecular and cellular biology.
[51] L. Greene,et al. Growth cone configuration and advance: a time-lapse study using video- enhanced differential interference contrast microscopy , 1988, Journal of Neuroscience.
[52] D. Stacey,et al. Cellular ras activity and tumor cell proliferation. , 1987, Experimental cell research.
[53] D. Burstein,et al. Activated N‐ras gene induces neuronal differentiation of PC12 rat pheochromocytoma cells , 1986, Journal of cellular physiology.
[54] A. Kimmelman,et al. R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells , 2000, Oncogene.
[55] Christian Ried,et al. Structural insights into phosphoinositide 3-kinase catalysis and signalling , 1999, Nature.
[56] P. Crespo,et al. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins , 1999, Oncogene.
[57] C. Der,et al. M-Ras/R-Ras3, a Transforming Ras Protein Regulated by Sos1, GRF1, and p120 Ras GTPase-activating Protein, Interacts with the Putative Ras Effector AF6* , 1999, The Journal of Biological Chemistry.
[58] J. Downward,et al. Multiple Ras Effector Pathways Contribute to G1Cell Cycle Progression* , 1999, The Journal of Biological Chemistry.
[59] Julian Downward,et al. Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell–matrix and cell–cell interaction , 1999, Current Biology.
[60] S. Oldham,et al. TC21 and Ras share indistinguishable transforming and differentiating activities , 1999, Oncogene.
[61] H. Paterson,et al. Activation of the Raf/MAP kinase cascade by the Ras‐related protein TC21 is required for the TC21‐mediated transformation of NIH 3T3 cells , 1999, The EMBO journal.
[62] K. Barker,et al. Ras-related TC21 is activated by mutation in a breast cancer cell line, but infrequently in breast carcinomas in vivo. , 1998, British Journal of Cancer.
[63] R. Wolthuis,et al. Activation of the Small GTPase Ral in Platelets , 1998, Molecular and Cellular Biology.
[64] Y. Matsuura,et al. Colocalization of Ras and Ral on the membrane is required for Ras-dependent Ral activation through Ral GDP dissociation stimulator , 1997, Oncogene.
[65] A. Kimmelman,et al. Identi ® cation and characterization of R-ras 3 : a novel member of the RAS gene family with a non-ubiquitous pattern of tissue distribution , 1997 .
[66] R. Wolthuis,et al. Stimulation of gene induction and cell growth by the Ras effector Rlf , 1997, The EMBO journal.
[67] J. Bos. Ras-like GTPases. , 1997, Biochimica et biophysica acta.
[68] J. Downward,et al. Interaction of Ras with phosphoinositide 3-kinase gamma. , 1997, The Biochemical journal.
[69] Asim Khwaja,et al. Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway , 1997, The EMBO journal.
[70] P. Warne,et al. Role of Phosphoinositide 3-OH Kinase in Cell Transformation and Control of the Actin Cytoskeleton by Ras , 1997, Cell.
[71] M. White,et al. RalGDS Functions in Ras- and cAMP-mediated Growth Stimulation* , 1997, The Journal of Biological Chemistry.
[72] G. Evan,et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.
[73] P. Warne,et al. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways , 1997, Current Biology.
[74] P. Tsichlis,et al. Akt Is a Direct Target of the Phosphatidylinositol 3-Kinase , 1996, The Journal of Biological Chemistry.
[75] C. Nobes,et al. Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways , 1996, Current Biology.
[76] Y. Matsuura,et al. Post-translational Modifications of Ras and Ral Are Important for the Action of Ral GDP Dissociation Stimulator* , 1996, The Journal of Biological Chemistry.
[77] L. J. van 't Veer,et al. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. , 1996, Oncogene.
[78] M. Wigler,et al. A Role for the Ral Guanine Nucleotide Dissociation Stimulator in Mediating Ras-induced Transformation* , 1996, The Journal of Biological Chemistry.
[79] M. Wigler,et al. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation , 1996, Molecular and cellular biology.
[80] J. Downward,et al. Activation of phosphoinositide 3‐kinase by interaction with Ras and by point mutation. , 1996, The EMBO journal.
[81] Gudrun Horn,et al. Differential Interaction of the Ras Family GTP-binding Proteins H-Ras, Rap1A, and R-Ras with the Putative Effector Molecules Raf Kinase and Ral-Guanine Nucleotide Exchange Factor , 1996, The Journal of Biological Chemistry.
[82] M. Barbacid,et al. The TC21 oncoprotein interacts with the Ral guanosine nucleotide dissociation factor. , 1996, Oncogene.
[83] T. Urano,et al. Ral‐GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. , 1996, The EMBO journal.
[84] P. Hawkins,et al. Initiation and maintenance of NGF-stimulated neurite outgrowth requires activation of a phosphoinositide 3-kinase. , 1996, Journal of cell science.
[85] C. Der,et al. Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers. , 1996, Oncogene.
[86] S. Aaronson,et al. A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line. , 1995, Oncogene.
[87] M. Barbacid,et al. Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation. , 1995, Oncogene.
[88] G. Cooper,et al. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. , 1995, Science.
[89] M. Wigler,et al. Multiple ras functions can contribute to mammalian cell transformation , 1995, Cell.
[90] P. Hawkins,et al. Activation of the small GTP-binding proteins rho and rac by growth factor receptors. , 1995, Journal of cell science.
[91] J. Bischoff,et al. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[92] C. Der,et al. R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells. , 1994, Oncogene.
[93] Michael J. Fry,et al. Phosphatidylinositol-3-OH kinase direct target of Ras , 1994, Nature.
[94] S. Aaronson,et al. A human oncogene of the RAS superfamily unmasked by expression cDNA cloning. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[95] C. Marshall,et al. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells , 1994, Cell.
[96] P. D’Eustachio,et al. Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation , 1994, Molecular and cellular biology.
[97] F. Grigorescu,et al. Involvement of phosphoinositide 3‐kinase in insulin‐ or IGF‐1‐induced membrane ruffling. , 1994, The EMBO journal.
[98] M. Kasuga,et al. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling , 1994, Current Biology.
[99] A. Hall,et al. R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation. , 1994, Oncogene.
[100] B. Dutrillaux,et al. Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma. , 1990, British Journal of Cancer.
[101] P. D’Eustachio,et al. Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line , 1990, Molecular and cellular biology.
[102] L. Greene,et al. Growth cone configuration and advance: a time-lapse study using video- enhanced differential interference contrast microscopy , 1988, Journal of Neuroscience.
[103] D. Stacey,et al. Cellular ras activity and tumor cell proliferation. , 1987, Experimental cell research.
[104] D. Burstein,et al. Activated N‐ras gene induces neuronal differentiation of PC12 rat pheochromocytoma cells , 1986, Journal of cellular physiology.